Inadequate Pharmacotherapeutic Data for Drugs Used in Children: What can be Done?

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.1, Iss.4, 1999-10, pp. : 245-249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Facilitating Adherence to Highly Active Antiretroviral Therapy in Children with HIV Infection: What Are the Issues and What Can Be Done?

By Pontali Emanuele

Pediatric Drugs, Vol. 7, Iss. 3, 2005-01 ,pp. : 137-149

Adis International

Access to resources Recommend Favorite

Drug pricing: what's to be done?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 318, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Colorectal Polyps in the Elderly: What Should Be Done?

By Miller Kenneth Waye Jerome D.

Drugs & Aging, Vol. 19, Iss. 6, 2002-01 ,pp. : 393-404

Adis International

Access to resources Recommend Favorite

What can be done to improve patient safety in phase I trials?

Reactions Weekly, Vol. 1, Iss. 1307, 2010-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Can the Fatal Toxicity of Antidepressant Drugs be Predicted with Pharmacological and Toxicological Data?

By Buckley N.A.

Drug Safety, Vol. 18, Iss. 5, 1998-05 ,pp. : 369-381

Adis International

Access to resources Recommend Favorite